Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Baymanon Sep 12, 2017 2:38pm

258 Views

Post# 26686164

RE:RE:RE:RE:Morgan Stanley Interview

[url=https://][/url]https://cc.talkpoint.com/morg007/091117a_as/?entity=149_QR0FFXY

I heard 350-400 million revenue in 3 years....thats is approximately 50 cents a share in revenue, so, only about 20 cents?? a share in profit. At a PE of 10, the stock price would be $2 USD in 2020. Double the PE for a growing company with growing revenues, and we are looking at $4 USD or about $5 Cdn stock price in 2020.

And that is without further delays, and hiccups from the FDA.

Surely that is not what all the 'Believers' were looking for by 2020 is it?